Lexicon Pharmaceuticals, Inc. (LXRX) Stock News & Chart

(LXRX)

Lexicon Pharmaceuticals, Inc.

Stock chart and latest news for Lexicon Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Lexicon Pharmaceuticals, Inc. News

PRO

Stock Titan

LXRX SEC Filings - Lexicon Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms

Apr 11, 2026 Yahoo Finance

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock most popular amongst private equity firms who own 48%, while individual investors hold 27%

Dec 23, 2025 MSN

LXRX stock up as NVO initiates phase I study of partnered obesity drug

Apr 10, 2026 simplywall.st

Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) Shares Climb 28% But Its Business Is Yet to Catch Up

Jan 22, 2026 Seeking Alpha

Lexicon Pharma spikes after insider buy

Feb 19, 2026 Stock Titan

Drug developer Lexicon raises $94.6M to fund pipeline and operations

Jan 30, 2026 Yahoo Finance

How The Lexicon Pharmaceuticals (LXRX) Story Is Shifting With Fine Tuned Targets And Trials

Feb 22, 2026 simplywall.st

Lexicon Pharmaceuticals (NASDAQ:LXRX) delivers shareholders notable 99% return over 1 year, surging 17% in the last week alone

Jan 17, 2026 Stock Titan

LXRX SEC Filings - Lexicon Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms

Apr 1, 2026 Yahoo Finance

H.C. Wainwright Raises its Price Target on Lexicon Pharmaceuticals, Inc. (LXRX) to $6 from $4 and Maintains a Buy Rating

Mar 12, 2026 Yahoo Finance

How The Lexicon Pharmaceuticals (LXRX) Story Is Shifting Around Pilavapadin And Valuation Assumptions

Apr 6, 2026 Stock Titan

A new obesity pill enters human testing, triggering $10M for Lexicon

Mar 23, 2026